100 related articles for article (PubMed ID: 17543424)
1. [Interleukin 13 and interleukin 13 receptor involvement in systemic sclerosis].
Granel B; Chevillard C; Dessein A
Rev Med Interne; 2007 Sep; 28(9):613-22. PubMed ID: 17543424
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-13 in fibrosis, particularly systemic sclerosis.
O'Reilly S
Biofactors; 2013; 39(6):593-6. PubMed ID: 23893513
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of interleukin 13 polymorphisms in systemic sclerosis.
Granel B; Chevillard C; Allanore Y; Arnaud V; Cabantous S; Marquet S; Weiller PJ; Durand JM; Harlé JR; Grange C; Frances Y; Berbis P; Gaudart J; de Micco P; Kahan A; Dessein A
Immunogenetics; 2006 Aug; 58(8):693-9. PubMed ID: 16832637
[TBL] [Abstract][Full Text] [Related]
4. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.
Chiaramonte MG; Mentink-Kane M; Jacobson BA; Cheever AW; Whitters MJ; Goad ME; Wong A; Collins M; Donaldson DD; Grusby MJ; Wynn TA
J Exp Med; 2003 Mar; 197(6):687-701. PubMed ID: 12642601
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-13 in systemic sclerosis.
Fuschiotti P
Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression.
Broen JC; Dieude P; Vonk MC; Beretta L; Carmona FD; Herrick A; Worthington J; Hunzelmann N; Riemekasten G; Kiener H; Scorza R; Simeon CP; Fonollosa V; ; Carreira P; Ortego-Centeno N; Gonzalez-Gay MA; Airo' P; Coenen MJ; Tsang K; Aliprantis AO; Martin J; Allanore Y; Radstake TR
J Rheumatol; 2012 Jan; 39(1):112-8. PubMed ID: 22045834
[TBL] [Abstract][Full Text] [Related]
7. Cytokine regulation of mucus production in a model of allergic asthma.
Cohn L; Whittaker L; Niu N; Homer RJ
Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496
[TBL] [Abstract][Full Text] [Related]
8. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
9. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis.
Chiaramonte MG; Cheever AW; Malley JD; Donaldson DD; Wynn TA
Hepatology; 2001 Aug; 34(2):273-82. PubMed ID: 11481612
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.
Li L; Zhu H; Zuo X
Front Immunol; 2018; 9():2663. PubMed ID: 30498500
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
Granel B; Bernard F; Chevillard C
Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma.
Matsushita M; Yamamoto T; Nishioka K
Int Arch Allergy Immunol; 2004 Dec; 135(4):348-56. PubMed ID: 15564778
[TBL] [Abstract][Full Text] [Related]
13. [Genetic factors predisposing to fibrosis in systemic sclerosis].
Granel B; Chevillard C; Dessein A
Rev Med Interne; 2005 Apr; 26(4):294-303. PubMed ID: 15820565
[TBL] [Abstract][Full Text] [Related]
14. T cells in systemic sclerosis: a reappraisal.
O'Reilly S; Hügle T; van Laar JM
Rheumatology (Oxford); 2012 Sep; 51(9):1540-9. PubMed ID: 22577083
[TBL] [Abstract][Full Text] [Related]
15. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.
Mavalia C; Scaletti C; Romagnani P; Carossino AM; Pignone A; Emmi L; Pupilli C; Pizzolo G; Maggi E; Romagnani S
Am J Pathol; 1997 Dec; 151(6):1751-8. PubMed ID: 9403725
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-13 in infectious diseases and allergy.
Brombacher F
Bioessays; 2000 Jul; 22(7):646-56. PubMed ID: 10878577
[TBL] [Abstract][Full Text] [Related]
18. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases.
Fenoglio D; Bernuzzi F; Battaglia F; Parodi A; Kalli F; Negrini S; De Palma R; Invernizzi P; Filaci G
Autoimmun Rev; 2012 Dec; 12(2):300-4. PubMed ID: 22634708
[TBL] [Abstract][Full Text] [Related]
19. Toxic Memories in Systemic Sclerosis.
Duffy L; O'Reilly S
J Invest Dermatol; 2017 May; 137(5):1003-1004. PubMed ID: 28411831
[TBL] [Abstract][Full Text] [Related]
20. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
Pertovaara M; Antonen J; Hurme M
Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
